HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alita A Miller Selected Research

Anti-Bacterial Agents (Antibiotics)

4/2024Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK).
11/2023Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii.
1/2021Rational design of a new antibiotic class for drug-resistant infections.
12/2020Zoliflodacin: An Oral Spiropyrimidinetrione Antibiotic for the Treatment of Neisseria gonorrheae, Including Multi-Drug-Resistant Isolates.
11/2020Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases.
1/2020In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
9/2014LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in Gram-negative pathogens.
11/2012Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors.
8/2008Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alita A Miller Research Topics

Disease

15Infections
04/2024 - 08/2008
3Acinetobacter Infections
01/2023 - 01/2021
1Coinfection
04/2024
1Bacterial Pneumonia
12/2023
1Melioidosis
01/2021
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1Gonorrhea
12/2020
1Gram-Negative Bacterial Infections
11/2020
1Communicable Diseases (Infectious Diseases)
09/2014
1Cross Infection (Nosocomial Infection)
06/2013
1Staphylococcal Infections
01/2013

Drug/Important Bio-Agent (IBA)

10sulbactam-durlobactamIBA
04/2024 - 01/2020
10LactamsIBA
04/2024 - 01/2020
9Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 08/2008
7Carbapenems (Carbapenem Antibiotics)IBA
04/2024 - 11/2020
4durlobactamIBA
12/2023 - 01/2021
3SulbactamFDA LinkGeneric
12/2023 - 01/2021
2Colistin (Coly-Mycin)FDA Link
04/2024 - 04/2024
2Cefpodoxime Proxetil (Vantin)FDA LinkGeneric
01/2021 - 11/2020
2ProdrugsIBA
01/2021 - 11/2020
2VaccinesIBA
01/2013 - 11/2012
1Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
04/2024
1ImipenemFDA Link
04/2024
1Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA
01/2023
1zoliflodacinIBA
12/2020
1EstersIBA
11/2020
1Polymyxins (Polymyxin)IBA
06/2013

Therapy/Procedure

4Therapeutics
04/2024 - 11/2020
1Mechanical Ventilators (Ventilator)
12/2023